Who this is for
This is where the two bodies part company, so read both rows rather than one.
USPSTF screens on age plus body weight: 35 to 70, and only if you have overweight or obesity.
ADA screens on age alone from 35, whatever you weigh, and separately at any age for people with overweight or obesity who carry one or more risk factors. ADA's own risk-factor list includes a first-degree relative with diabetes; African American, Latino, Native American or Asian American race, ethnicity or ancestry; a history of cardiovascular disease; hypertension; low HDL or high triglycerides; polycystic ovary syndrome; and physical inactivity.
Screening is for people without symptoms. Thirst, frequent urination, blurred vision or unexplained weight loss is a reason to be tested now, on a different pathway.
Where the recommendations diverge
- USPSTF 35 to 70
- ADA Not age-bounded
- ADA 35 and older
The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.
Our note: Interval taken from the same page, which is candid about the gap: "Evidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels." The 2021 statement lowered the starting age from 40 to 35.
Testing for prediabetes or type 2 diabetes in asymptomatic people should be considered in adults of any age with overweight or obesity who have one or more risk factors (Table 2.5).
Our note: Recommendation 2.12a of Standards of Care in Diabetes 2026, Section 2. The row is left with no age bounds because the recommendation states none: it says "of any age". Recommendation number and the trailing evidence grade B are dropped from the quote; the grade is in the grade cell. SOURCING: diabetesjournals.org, ADA's own host, refused every request from us (HTTP 403), so the text is quoted from the publisher-deposited full text in PubMed Central. doi 10.2337/dc26-S002.
Testing for prediabetes or type 2 diabetes in asymptomatic people should be considered in adults of any age with overweight or obesity who have one or more risk factors (Table 2.5). ... For all other people, screening should begin at age 35 years.
Our note: Recommendations 2.12a and 2.12b, consecutive in ADA's own numbered list. The ellipsis omits Table 2.5, the risk-factor list 2.12a points at, which the page interleaves between them; the lead-in is kept because "all other people" has no referent without it. The grade cell holds the B ADA attaches to 2.12a and 2.12b. The interval comes from a SEPARATE recommendation, 2.12c, graded C, not B: repeat screening at "a minimum of 3-year intervals is reasonable, sooner with symptoms or change in risk". SOURCING: as the row above, from PubMed Central because ADA's own host returns 403.
Why they differ
Both bodies start at 35. Only one of them screens you if you are a healthy weight, and that is the whole disagreement.
- USPSTF (2021) recommends screening adults 35 to 70 who have overweight or obesity, and stops at 70. Weight is an eligibility condition, not a risk factor to weigh.
- ADA (Standards of Care 2026) recommends that for everyone who is not already covered by its risk-factor rule, "screening should begin at age 35 years", with no weight condition and no upper age. ADA's own supporting text gives the reason in one line: "Age is a major risk factor for diabetes."
The practical effect is large. A 45-year-old of normal weight with a parent who has type 2 diabetes is not recommended for screening by USPSTF and is recommended for it by ADA. So is a 72-year-old of any weight. So is anyone lean with hypertension, low HDL, PCOS or a South Asian or East Asian background, which ADA covers by lowering the BMI threshold to 23 for people of Asian ancestry.
They also differ on the upper edge. USPSTF's recommendation runs to 70 and ADA states no ceiling at all. This is a difference in what each body is willing to state, not evidence that screening after 70 is harmful. We read the 2021 statement looking for a rationale for the age-70 cutoff, including its Practice Considerations and its five-bullet Research Needs and Gaps section, and found none. What that section does say on the point is that the question is open: among the gaps it lists is "Clinical trials and additional modeling studies are needed to better elucidate the optimal frequency of screening and the age at which to start and stop screening." So USPSTF names the stop age as something still to be settled by research, rather than giving a reason for setting it at 70.
On interval they nearly agree, and both admit how thin the evidence is. USPSTF: screening every three years "may be a reasonable approach". ADA: repeat screening at a minimum of three-year intervals "is reasonable, sooner with symptoms or change in risk". Neither claims better than reasonable.
USPSTF is not unaware of the gap. Its own page records ADA's position under Recommendations of Others, describing it as universal screening for all adults over a stated age regardless of risk factors.
3 documents set the numbers on this page. The oldest was published in 2021, the newest in 2025.
- USPSTF recommendation
- American Diabetes Association recommendation
- The American Diabetes Association Releases Standards of Care in Diabetes 2026 (December 8, 2025) 2025
We last re-read these sources on . How we verify.
What the test involves
A single blood draw for A1C, which requires no fasting and can be added to any other blood test; a fasting glucose, which needs eight hours without food or drink other than water and is usually done first thing; or an oral glucose tolerance test, which takes two hours in the clinic. ADA adds a practical warning about the last of these: adequate carbohydrate intake, at least 150 grams a day, should be assured for three days before the test, or the result can be misleading.
If the result is abnormal
A result in the prediabetes range is the one that most often gets shrugged off, and both bodies treat it as the point of the exercise. USPSTF writes the referral into the recommendation itself: clinicians should offer or refer patients with prediabetes to effective preventive interventions. ADA asks for yearly testing from then on rather than a three-year gap.
A result in the diabetes range is confirmed with a second test before the diagnosis is made, unless glucose is unequivocally high or you have classic symptoms.
More on this screening
Frequently asked questions
I am 45 and a normal weight. Should I be tested?
ADA says yes: from 35, screening applies to everyone not already covered by its risk-factor rule, with no weight condition. USPSTF says its recommendation does not reach you, because it screens 35 to 70 only in adults with overweight or obesity. Both are current. If you have a family history, high blood pressure, low HDL, high triglycerides, PCOS or an Asian, Black, Latino or Native American background, ADA's risk-factor rule is the one to raise with your clinician.
A1C, fasting glucose or the two-hour test. Does it matter which?
ADA states that all three are appropriate for screening. A1C is the least disruptive because it needs no fasting. The tests do not always agree with each other, which is why a diabetes-range result gets confirmed with a repeat test before anything is diagnosed.
How often, if my first test is normal?
Every three years is what both bodies land on, and both say the evidence for that number is limited rather than strong. ADA adds that sooner is right if symptoms appear or your risk changes, giving weight gain as its example.
Why does USPSTF stop at 70?
Its recommendation covers adults 35 to 70; it does not extend a recommendation past 70 in either direction. ADA sets no upper age. This is a difference in what each body is willing to state, not evidence that screening after 70 is harmful.